Johnson & Johnson | featured news

J&J recall saga continues with Children's Benadryl

Johnson & Johnson's McNeil unit has begun a voluntary recall of Children's Benadryl allergy tablets, in cherry and grape flavors, citing insufficiencies in the development of the manufacturing process.

 

J&J Heart Drug Provided Little Symptom Benefit

J&J Heart Drug Provided Little Symptom Benefit

Results of a long-awaited clinical trial show J&J's drug nesiritide provides limited relief from breathing problems for patients with acute heart failure.

 

J&J CEO faces U.S. lawmakers over string of recalls

Johnson & Johnson's massive recall of faulty medicines, including a quiet buyback of its Motrin painkiller, has angered U.S. lawmakers who will question the company's chief executive and a senior health regulator on Thursday.

 

Did drugmaker hide birth control patch risks?

According to private internal documents obtained by NBC News, pharmaceutical giant Johnson & Johnson may have known about deadly risks of its birth control patch Ortho Evra years ago, but kept the product on the market anyway.

 

J&J AIDS drug shows promise

J&J AIDS drug shows promise

Two pivotal trials of a Johnson & Johnson experimental HIV drug found it worked as well as an existing drug, with fewer side effects but also with nearly twice as many patients failing to respond to treatment.

 

J&J says latest drug recalls involved 3 million bottles

J&J says latest drug recalls involved 3 million bottles

Johnson & Johnson provided additional details on Friday about its two most recent recalls of Tylenol and other over-the-counter drugs, saying the actions on Thursday and June 15 involved a total of about 3 million bottles of the medicines.

 

Johnson & Johnson heiress dead

Johnson & Johnson heiress dead

Casey Johnson, the heiress to the Johnson & Johnson fortune who recently made tabloid headlines with a purported engagement to reality star Tila Tequila, has died at age 30.

 

J&J to cut 7,000 to 8,000 jobs

Johnson & Johnson will eliminate about 6 percent to 7 percent of its global workforce, or some 7,000 to 8,000 positions, as the diversified healthcare company restructures and seeks cost savings, the company said on Tuesday.

 

Johnson & Johnson buys 18 percent stake in Crucell

Health care giant Johnson & Johnson is jumping into the increasingly hot vaccine business by taking an 18 percent stake in Dutch biotechnology company Crucell NV and focusing more on preventive medicine....

 

Infant, children's liquid Tylenol recalled

Johnson & Johnson's McNeil unit is voluntarily recalling 57 lots of infants' and children's liquid Tylenol products because of possible bacterial contamination.

 

Subscribe to this RSS topic: Syndicate content